Management options for localized prostate cancer include radical prostatectomy, external radiation therapy, brachytherapy, and watchful waiting. Improvements in treatment techniques have resulted in fewer side effects. Nevertheless, long-term complications such as erectile dysfunction (ED) continue to affect a significant percentage of men treated for prostate cancer and can have a distressing and debilitating effect on the patient's quality of life.
Methods
The author reviews both the prevalence and the current options for the management of ED secondary to treatment for clinically localized prostate cancer.
Results
The ability to preserve potency after prostate cancer treatment is controversial, with reports ranging from 10%-90%. For patients complaining of impotence, efficacious alternatives are available such as oral drugs, intraurethral alprostadil, vacuum devices, intracavernous injections, and penile prostheses.
Conclusions
Sexual function is an integral part of patient satisfaction and quality of life. Although ED is a frequent complication of definitive treatment of localized prostate cancer, a variety of treatment options are now available to maximize quality of life despite age and other comorbidities.
References
1.
NIH Consensus Conference.Impotence. NIH Consensus Development Panel on Impotence.JAMA.1993; 270: 83–90.
2.
FeldmanH.A., GoldsteinI., HatzichristouD.G.. Impotence and its medical psychosocial correlates: results of the Massachusetts Male Aging Study.J Urol.1994; 151: 54–61.
MongaM.. Sexual dysfunction in cancer patients.The Handbook of Sexual Dysfunction.1999; 35–38. Chap 7.
5.
SiegelT., MoulJ.W., SpevakM.. The development of erectile dysfunction in men treated for prostate cancer.J Urol.2001; 165: 430–435.
6.
Sanchez-OrtizR.F., BroderickG.A., RovnerE.S.. Erectile function and quality of life after interstitial radiation therapy for prostate cancer.Int J Impot Res.2000; S18–24.
7.
MatzkinH., KaverI., StengerA.. I125 prostate brachytherapy: short-term results of the first 150 patients in Israel [Hebrew].Harefuah.2001; 140: 694–698, 807.
8.
StockR.G., KaoJ., StoneN.N.. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.J Urol.2001; 165: 436–439.
9.
MerrickG.S., WallnerK., ButlerW.M.. Short-term sexual function after prostate brachytherapy.Int J Cancer.2001; 96: 313–319.
10.
TurnerS.L., AdamsK., BullC.A.. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation.Urology.1999; 54: 124–129.
11.
ZelefskyM.J., WallnerK.E., LingC.C.. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.J Clin Oncol.1999; 17: 517–522.
12.
WilderR.B., ChouR.H., RyuJ.K.. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: prelminary results.Am J Clin Oncol.2000; 23: 330–333.
13.
al-AbanyM., SteineckG., Agren CronqvistA.K.. Improving the preservation of erectile function after external-beam radiation therapy for prostate cancer.Radiother Oncol.2000; 57: 201–206.
14.
PottersL., TorreT., FearnP.A.. Potency after permanent prostate brachytherapy for localized prostate cancer.Int J Radiat Oncol Biol Phys.2001; 50: 1235–1242.
15.
MadalinskaJ.B., Essink-BotM.L., de KoningH.J.. Health-related quality-of- life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.J Clin Oncol.2001; 19: 1619–1628.
16.
OnikG.. Image-guided prostate cryosurgery: state of the art.Cancer Control.2001; 8: 522–531.
17.
CatalonaW.J., CarvalhalG.F., MagerD.E.. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies.J Urol.1999; 162: 433–438.
18.
McCammonK.A., KolmP., MainB.. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer.Urology.1999; 54: 509–516.
19.
WalshP.C.. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.J Urol.2000; 163: 1802–1807.
20.
GralnekD., WessellsH., CuiH.. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy.J Urol.2000; 163: 1166–1170.
21.
WalshP.C., MarschkeP., RickerD.. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy.Urology.2000; 55: 58–61.
22.
KawanishiY., LeeK.S., KimuraK.. Effect of radical retropubic prostatectomy on erectile function, evaluated before and after surgery using colour Doppler ultrasonography and nocturnal penile tumescence monitoring.BJU Int.2001; 88: 244–247.
23.
StanfordJ.L., FengZ., HamiltonA.S.. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.JAMA.2000; 283: 354–360.
24.
KaoT.C., CruessD.F., GarnerD.. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy.J Urol.2000; 163: 858–864.
25.
Valdivia NavarroP., GonzalvoA., Blas MarinM.. Quality of life after radical prostatectomy [Spanish].Actas Urol Esp.1997; 21: 903–908.
26.
RabbaniF., StapletonA.M., KattanM.W.. Factors predicting recovery of erections after radical prostatectomy.J Urol.2000; 164: 1929–1934.
27.
FormentiS.C., LieskovskyG., SkinnerD.. Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy.Urology.2000; 56: 453–458.
28.
LitwinM.S., FlandersS.C., PastaD.J.. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.Urology.1999; 54: 503–508.
29.
JardinA., WagnerG., KhouryS.. Proceedings: First International Consultatin on Erectire Dysfunction.Paris: SCI; 2000. In press.
30.
JarowJ.P., BurnettA.L., GeringerA.M.. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.J Urol.1999; 162: 722–725.
31.
BanielJ., IsrailovS., SegenreichE.. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropublic prostatectomy.BJU Int.2001; 88: 58–62.
32.
ValeJ.. Erectile dysfunction following radical therapy for prostate cancer.Radiother Oncol.2000; 57: 301–305.
33.
ZelefskyM.J., McKeeA.B., LeeH.. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate.Urology.1999; 53: 775–778.
34.
ZippeC.D., KediaA.W., KediaK.. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra).Urology.1998; 52: 963–966.
35.
WeberD.C., BieriS., KurtzJ.M.. Prospective pilot study sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.J Clin Oncol.1999; 17: 3444–3449.
36.
MerrickG.S., ButlerW.M., LiefJ.H.. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction.Urology.1999; 53: 1112–1116.
37.
KediaS., ZippeC.D., AgarwalA.. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer.Urology.1999; 54: 308–312.
38.
Padma-NathanH., GiulianoF.. Oral drug therapy for erectile dysfunction.Urol Clin North Am.2001; 28: 321–334.
39.
NehraA., HakimL.S., BarrettD.M.. Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring noninvasive therapy: 18-month follow-up.J Urol.2000; 163(4 suppl): 885. Abstract.
40.
MontorsiF., GuazzoniG., StrambiL.F.. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.J Urol.1997; 158: 1408–1410.
41.
LebretT., HerveJ.M., YonneauL.. Erectile dysfunction after radical prostatectomy: value of preoperative programming of intracavernous injections [French].Prog Urol.1999; 9: 483–488.
